Determining the effects of antiepileptic drugs on cognitive function in pediatric patients with epilepsy

Journal of Child Neurology

Volumn 19, Issue SUPPL. 1, 2004, Pages

  Bourgeois, Blaise F D ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; CARBAMAZEPINE; ETHOSUXIMIDE; ETIRACETAM; FELBAMATE; GABAPENTIN; LAMOTRIGINE; OXCARBAZEPINE; PHENOBARBITAL; PHENYTOIN; PLACEBO; TIAGABINE; TOPIRAMATE; VALPROIC ACID; ZONISAMIDE;

APLASTIC ANEMIA; ATTENTION DEFICIT DISORDER; CHILD; CHILD CARE; CLINICAL TRIAL; COGNITION; COGNITIVE DEFECT; DISEASE EXACERBATION; DRUG EFFICACY; EPILEPSY; HUMAN; INTELLIGENCE; LEARNING DISORDER; LIVER TOXICITY; MEMORY DISORDER; MOTOR DYSFUNCTION; NEUROPATHOLOGY; PATIENT MONITORING; PRIORITY JOURNAL; PSYCHOSOCIAL DISORDER; REVIEW; SEIZURE;

EID: 8344274387     PISSN: 08830738     EISSN: None     Source Type: Journal    
DOI: 10.1177/088307380401900103     Document Type: Review

References (70)

1. Bourgeois BFD, Prensky AL, Palkes HS, et al: Intelligence in epilepsy: A prospective study in children. Ann Neurol 1983; 14:438-444.
2. Rodin EA, Schmaltz S, Twitty G: Intellectual functions of patients with childhood-onset epilepsy. Dev Med Child Neurol 1986;28: 25-33.
3. Ellenberg JH, Hirtz DG, Nelson KB: Do seizures in children cause intellectual deterioration? N Engl J Med 1986;314:1085-1088.
4. Deonna T, Zesiger P, Davidoff V, et al: Benign partial epilepsy of childhood: A longitudinal neuropsychological and EEG study of cognitive function. Dev Med Child Neurol 2000;42:595-603.
5. Dodson WE: Epilepsy, cerebral palsy, and IQ, in Pellock JM, Dodson WE, Bourgeois BFD (eds): Pediatric Epilepsy: Diagnosis and Therapy, 2nd ed. New York, Demos Medical Publishing, Inc, 2001, 613-627.
6. Jokeit H, Daamen M, Zang H, et al: Seizures accelerate forgetting in patients with left-sided temporal lobe epilepsy. Neurology 2001;57:125-126.
7. Siebelink BM, Bakker DJ, Binnie CD, Kasteleijn-Nolst Trenite DG: Psychological effects of subclinical epileptiform EEG discharges in children. II. General intelligence tests. Epilepsy Res 1988;2:117-121.
8. Bourgeois BFD: Differential cognitive effects of antiepileptic drugs. J Child Neurol 2002;17:2S28-2S33.
9. Austin JK Comparison of child adaptation to epilepsy and asthma. J Child Adolesc Psychiatr Ment Health Nurs 1989;2:139-144.
10. Trimble MR, Thompson PJ: Anticonvulsant drugs, cognitive function, and behavior. Epilepsia 1983;24(Suppl 1):S55-S63.
11. Holmes GL: Epilepsy in the developing brain: Lessons from the laboratory and clinic. Epilepsia 1997;38:12-30.
12. Aldenkamp AP, Vermeulen J: Cognitive side effects of antiepileptic drugs, in Pellock JM, Dodson EW, Bourgeois BFD (eds): Pediatric Epilepsy: Diagnosis and Therapy. New York, Demos Medical Publishing, Inc, 2001, 629-635.
13. Bourgeois BFD: Relationship between anticonvulsant drugs and learning disabilities. Semin Neurol 1991;11:14-19.
14. Bourgeois BFD: Antiepileptic drugs, learning, and behavior in childhood epilepsy. Epilepsia 1998;39:913-921.
15. Leppik IE: Issues in the treatment of epilepsy. Epilepsia 2001; 42(Suppl 4):1-6.
16. Farwell JR, Lee YJ, Hirtz DG, et al: Phenobarbital for febrile seizures - Effects on intelligence and on seizure recurrence. N Engl J Med 1990;322:364-369.
17. Camfield CS, Chaplin MA, Doyle AB, et al: Side effects of phenobarbital in toddlers; behavioral and cognitive aspects. J Pediatr 1979;95:361-365.
18. Riva D, Devoti M: Discontinuation of phenobarbital in children: Effects on neurocognitive behavior. Pediatr Neurol 1996;14:36-40.
19. Gallassi R, Morreale A, Di Sarro R, et al: Cognitive effects of antiepileptic drug discontinuation. Epilepsia 1992;33(Suppl 6):S41-S44.
20. Wolf SM, Forsythe A, Stunden AA, et al: Long-term effect of phenobarbital on cognitive function in children with febrile convulsions. Pediatrics 1981;68:820-823.
21. Hellström B, Barlach-Christoffersen M: Influence of phenobarbital on the psychomotor development and behaviour in preschool children with convulsions. Neuropädiatrie 1980;11:151-160.
22. Vining EPG, Mellits ED, Dorsen MM, et al: Psychologic and behavioral effects of antiepileptic drugs in children: A double-blind comparison between phenobarbital and valproic acid. Pediatrics 1987;80:165-174.
23. Calandre EP, Dominguez-Granados R, Gomez-Rubio M, Molina-Font JA: Cognitive effects of long-term treatment with phenobarbital and valproic acid in school children. Acta Neurol Scand 1990;81:504-506.
24. Chen YJ, Chow JC, Lee IC: Comparison of the cognitive effect of anti-epileptic drugs in seizure-free children with epilepsy before and after drug withdrawal. Epilepsy Res 2001;44:65-70.
25. Gallassi R, Lorusso S, Stracciari A, et al: Withdrawal of phenobarbital and carbamazepine in epileptic patients: A preliminary neuropsychological report. Acta Neurol Scand 1986;74:59-62.
26. Mitchell WG, Chavez JM: Carbamazepine versus phenobarbital for partial onset seizures in children. Epilepsia 1987;28:56-60.
27. Meador KJ, Loring DW, Huh K, et al: Comparative cognitive effects of anticonvulsants. Neurology 1990;40:391-394.
28. Gallassi R, Morreale A, Lorusso S, et al: Cognitive effects of phenytoin during monotherapy and after withdrawal. Acta Neurol Scand 1987;75:258-261.
29. Aman MG, Werry JS, Paxton JW, Turbott SH: Effects of phenytoin on cognitive-motor performance in children as a function of drug concentration, seizure type, and time of medication. Epilepsia 1994;35:172-180.
30. Thompson P, Huppert FA, Trimble M: Phenytoin and cognitive function: Effects on normal volunteers and implications for epilepsy. Br J Clin Psychol 1981;20:155-162.
31. Meador KJ, Loring DW, Abney OL, et al: Effects of carbamazepine and phenytoin on EEG and memory in healthy adults. Epilepsia 1993;34:153-157.
32. Meador KJ, Loring DW, Allen ME, et al: Comparative cognitive effects of carbamazepine and phenytoin in healthy adults. Neurology 1991;41:1537-1540.
33. Forsythe I, Butler R, Berg I, McGuire R: Cognitive impairment in new cases of epilepsy randomly assigned to carbamazepine, phenytoin and sodium valproate. Dev Med Child Neurol 1991; 33:524-534.
34. Aldenkamp AP, Alpherts WCJ, Blennow G, et al: Withdrawal of antiepileptic medication in children - Effects on cognitive function: The multicenter Holmfrid study. Neurology 1993;43:41-50.
35. Stores G, Williams PL, Styles E, Zaiwalla Z: Psychological effects of sodium valproate and carbamazepine in epilepsy. Arch Dis Child 1992;67:1330-1337.
36. Seidel WT, Mitchell WG: Cognitive and behavioral effects of carbamazepine in children: Data from benign rolandic epilepsy. J Child Neurol 1999;14:716-723.
37. Mandelbaum DE, Burack GD: The effect of seizure type and medication on cognitive and behavioral functioning in children with idiopathic epilepsy. Dev Med Child Neurol 1997;39:731-735.
38. Aman MG, Werry JS, Paxton JW, et al: Effects of carbamazepine on psychomotor performance in children as a function of drug concentration, seizure type, and time of medication. Epilepsia 1990;31:51-60.
39. Gallassi R, Morreale A, Lorusso S, et al: Cognitive effects of valproate. Epilepsy Res 1990;5:160-164.
40. Trimble MR, Thompson PJ: Sodium valproate and cognitive function. Epilepsia 1984;25(Suppl 1):S60-S64.
41. Aman MG, Weny JS, Paxton JW, Turbott SH: Effect of sodium valproate on psychomotor performance in children as a function of dose, fluctuations in concentration, and diagnosis. Epilepsia 1987;28:115-124.
42. Physicians' Desk Reference, 57th ed. Montvale, NJ, Thomson PDR, 2003.
43. Leppik IE: Safety and Tolerability Considerations in Managing Intractable Partial Epilepsy: Impact of the New Antiepileptic Drugs. The Protocols Series: Guidelines From Experts in Epilepsy, no. 2. Ghent, NY, Galen Press, 2001.
44. Leach JP, Girvan J, Paul A, Brodie MJ: Gabapentin and cognition: A double blind, dose ranging, placebo controlled study in refractory epilepsy. J Neurol Neurosurg Psychiatry 1997; 62:372-376.
45. Meador KJ, Loring DW, Ray PG, et al: Differential cognitive effects of carbamazepine and gabapentin. Epilepsia 1999;40:1279-1285.
46. Martin R, Meador K, Turrentine L, et al: Comparative cognitive effects of carbamazepine and gabapentin in healthy senior adults. Epilepsia 2001;42:764-771.
47. Salinsky MC, Binder LM, Oken BS, et al: Effects of gabapentin and carbamazepine on the EEG and cognition in healthy volunteers. Epilepsia 2002;43:482-490.
48. Martin R, Kuzniecky R, Ho S, et al: Cognitive effects of topiramate, gabapentin, and lamotrigine in healthy young adults. Neurology 1999;52:321-327.
49. Marciani MG, Stanzione P, Mattia D, et al: Lamotrigine add-on therapy in focal epilepsy: Electroencephalographic and neuropsychological evaluation. Clin Neuropharmacol 1998;21:41-47.
50. Aldenkamp AP, Mulder OG, Overweg J: Cognitive effects of lamotrigine as first-line add-on in patients with localization-related (partial) epilepsy. J Epilepsy 1997;10:117-121.
51. Meador KJ, Loring DW, Ray PG, et al: Differential cognitive and behavioral effects of carbamazepine and lamotrigine. Neurology 2001;56:1177-1182.
52. Aldenkamp AP, Arends J, Bootsma HPR, et al: Randomized double-blind parallel-group study comparing cognitive effects of a lowdose lamotrigine with valproate and placebo in healthy volunteers. Epilepsia, 2002;43:19-26.
53. van Rijckevorsel K: The 'number needed to treat' with levetiracetam (LEV): Comparison with the other new antiepileptic drugs (AEDs). Seizure 2002;11(Suppl A):235-236.
54. Tatum WO IV, French JA, Faught E, et al: Postmarketing experience with topiramate and cognition. Epilepsia 2001;42:1134-1140.
55. Aldenkamp AP, Baker G, Mulder OG, et al: A multicenter, randomized clinical study to evaluate the effect on cognitive function of topiramate compared with valproate as add-on therapy to carbamazepine in patients with partial-onset seizures. Epilepsia 2000;41:1167-1178.
56. Kockelmann E, Elger CE, Helmstaedter C: Significant improvement in frontal lobe associated neuropsychological functions after withdrawal of topiramate in epilepsy patients. Epilepsy Res 2003;54:171-178.
57. Lee S, Sziklas V, Andermann F, et al: The effects of adjunctive topiramate on cognitive function in patients with epilepsy. Epilepsia 2003;44:339-347.
58. Burton LA, Harden C: Effect of topiramate on attention. Epilepsy Res 1997;27:29-32.
59. Meador KJ, Loring DW, Hulihan JF, et al: Differential cognitive and behavioral effects of topiramate and valproate. Neurology 2003;60:1483-1488.
60. Kälviäinen R, Äikiä M, Mervaala E, et al: Long-term cognitive and EEG effects of tiagabine in drug-resistant partial epilepsy. Epilepsy Res 1996;25:291-297.
61. Dodrill CB, Arnett JL, Sommerville KW, Shu V: Cognitive and quality of life effects of differing dosages of tiagabine in epilepsy. Neurology 1997;48:1025-1031.
62. Sveinbjornsdottir S, Sander JWAS, Patsalos PN, et al: Neuropsychological effects of tiagabine, a potential new antiepileptic drug. Seizure 1994;3:29-35.
63. Dodrill CB, Arnett JL, Deaton R, et al:Tiagabine versus phenytoin and carbamazepine as add-on therapies: Effects on abilities, adjustment, and mood. Epilepsy Res 2000;42:123-132.
64. Antiepileptic drugs [new drugs of 2000]. J Am Pharm Assoc 2001;41:229-272. Available at: http://www.medscape.com/viewarticle/406719. Accessed December 9, 2003.
65. Neyens LGJ, Alpherts WCJ, Aldenkamp AP: Cognitive effects of a new pyrrolidine derivative (levetiracetam) in patients with epilepsy. Prog Neuropsychopharmacol Biol Psychiatry 1995; 19: 411-419.
66. Cramer JA, Arrigo C, Van Hammée G, et al: Effect of levetiracetam on epilepsy-related quality of life. Epilepsia 2000;41:868-874.
67. Sabers A, Møller A, Dam M, et al: Cognitive function and anticonvulsam therapy: Effect of monotherapy in epilepsy. Acta Neurol Scand 1995;92:19-27.
68. Äikiä M, Kälviäinen R, Sivenius J, et al: Cognitive effects of oxcarbazepine and phenytoin monotherapy in newly diagnosed epilepsy: one year follow-up. Epilepsy Res 1992;11:199-203.
69. Curran HV, Java R: Memory and psychomotor effects of oxcarbazepine in healthy human volunteers. Eur J Clin Pharmacol 1993;44:529-533.
70. Berent S, Sackellares JC, Giordani B, et al: Zonisamide (CI-912) and cognition: Results from preliminary study. Epilepsia 1987;28:61-67.